Bone defects are mainly caused by inflammation, trauma and injury. The use of grafts is therefore necessary to replace damaged tissue. Nowadays, autografts remain the gold standard, despite their drawbacks in terms of availability. Therefore, the research into synthetic bone substitutes arises as a viable alternative. However, the use of a graft just a scaffold is limited to prevent or fight infections, due to the lack of antimicrobial properties that are needed to fight the infections cause. In this case, ideally, a bone substitute should be osteoconductive, osteoinductive and have antimicrobial properties. To correctly validate these new developed substitutes, research needs tools to test these new types of materials and evaluate their efficacy against pathogens, and cocultures seem to be one of the most promising solutions. The aim of this thesis work was to create a prokaryotic-eukaryotic coculture as an in vitro tool for the evaluation of biomaterials with dual-sequential release of antimicrobial and bone regeneration drugs. The bacterium chosen was Staphylococcus aureus because, according to statistics, it is the pathogen that most frequently causes infections during bone tissue repair and/or regeneration in humans. Given the differences observed in the literature papers, a workable protocol for creating the coculture was first implemented using MG-63 cells. Specifically, a bacterial concentration of 10^3 CFU/mL and a contamination time of 2 h were identified as important parameters for the coculture creation. Subsequently, the above protocol was adopted to create a coculture with MSCs, which was used to test porous ceramic microspheres loaded with gentamicin and alendronate, which confer antimicrobial and osteodifferentiation properties, respectively. For this purpose, resazurin cell viability assay and fluorescence microscopy were used to analyze the cells during this experiment. The possibility of applying these assays to the coculture and obtaining results has validated the coculture itself. This means that it has been proven that this coculture can be used as a useful and advantageous tool for the evaluation of biomaterials with antimicrobial and osteoregenerative purposes.

Establishment of a coculture in vitro model for assessing biomaterials for bone regeneration

BARBOLINI, GIORGIA
2022/2023

Abstract

Bone defects are mainly caused by inflammation, trauma and injury. The use of grafts is therefore necessary to replace damaged tissue. Nowadays, autografts remain the gold standard, despite their drawbacks in terms of availability. Therefore, the research into synthetic bone substitutes arises as a viable alternative. However, the use of a graft just a scaffold is limited to prevent or fight infections, due to the lack of antimicrobial properties that are needed to fight the infections cause. In this case, ideally, a bone substitute should be osteoconductive, osteoinductive and have antimicrobial properties. To correctly validate these new developed substitutes, research needs tools to test these new types of materials and evaluate their efficacy against pathogens, and cocultures seem to be one of the most promising solutions. The aim of this thesis work was to create a prokaryotic-eukaryotic coculture as an in vitro tool for the evaluation of biomaterials with dual-sequential release of antimicrobial and bone regeneration drugs. The bacterium chosen was Staphylococcus aureus because, according to statistics, it is the pathogen that most frequently causes infections during bone tissue repair and/or regeneration in humans. Given the differences observed in the literature papers, a workable protocol for creating the coculture was first implemented using MG-63 cells. Specifically, a bacterial concentration of 10^3 CFU/mL and a contamination time of 2 h were identified as important parameters for the coculture creation. Subsequently, the above protocol was adopted to create a coculture with MSCs, which was used to test porous ceramic microspheres loaded with gentamicin and alendronate, which confer antimicrobial and osteodifferentiation properties, respectively. For this purpose, resazurin cell viability assay and fluorescence microscopy were used to analyze the cells during this experiment. The possibility of applying these assays to the coculture and obtaining results has validated the coculture itself. This means that it has been proven that this coculture can be used as a useful and advantageous tool for the evaluation of biomaterials with antimicrobial and osteoregenerative purposes.
2022
Establishment of a coculture in vitro model for assessing biomaterials for bone regeneration
coculture
staphylococcus
bone regeneration
biomaterials
File in questo prodotto:
File Dimensione Formato  
Barbolini_Giorgia.pdf

embargo fino al 11/12/2026

Dimensione 2.78 MB
Formato Adobe PDF
2.78 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/59663